Most U.S. Adults Unaware of Forever Chemicals
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 19, 2023 -- Three-quarters of U.S. adults do not know what forever chemicals are, according to a study published online Nov. 16 in PLOS ONE.
T. Allen Berthold, Ph.D., from Texas A&M AgriLife in College Station, and colleagues administered a nationwide survey to assess awareness of per- and polyfluoroalkyl substances (PFAS) and community contamination; awareness of PFAS-containing products and intentions to change product use; and awareness and concern about PFAS in drinking water. The analysis included data from 1,100 online respondents.
The researchers found that almost half the respondents had never heard of PFAS and did not know what it is (45.1 percent), while an additional 31.6 percent had heard of PFAS but did not know what it is. The vast majority of respondents (97.4 percent) did not believe their drinking water had been impacted by PFAS. There were no associations between demographic factors and knowledge of PFAS or levels of concern with PFAS in drinking water. Known community exposure was the strongest predictor of PFAS awareness, and respondents aware of community exposure were more likely to change their use of items with potential PFAS contamination and answer that their drinking water sources were also contaminated with PFAS.
"PFAS information and health risks need to be better communicated to the public to help increase awareness," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-20 06:15
Read more
- Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
- Study Identifies Risk Factors Associated With Severe Stroke
- U.S. Alcohol Intake Rose During Pandemic, and for Years After
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- E. Coli Illnesses Linked to McDonald's Quarter Pounders Climb to 104
- 1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions